Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.
Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, Thompson W, Karns RA, Mayhew CN, McGrath PS, McCauley HA, Zhang RR, Lewis K, Hakozaki S, Ferguson A, Saiki N, Yoneyama Y, Takeuchi I, Mabuchi Y, Akazawa C, Yoshikawa HY, Wells JM, Takebe T.
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
Recent insights into lysosomal acid lipase deficiency.
Korbelius M, Kuentzel KB, Bradić I, Vujić N, Kratky D.
Trends Mol Med. 2023 Jun;29(6):425-438. doi: 10.1016/j.molmed.2023.03.001. Epub 2023 Apr 5.
Cerebrotendinous xanthomatosis.
Berginer VM, Salen G, Shefer S.
Neurol Clin. 1989 Feb;7(1):55-74.
Sebelipase alfa.
[No authors listed]
2016 Mar 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Rare diseases presenting with hemophagocytic lymphohistiocytosis.
Kanegane H, Noguchi A, Yamada Y, Yasumi T.
Pediatr Int. 2023 Jan-Dec;65(1):e15516. doi: 10.1111/ped.15516.
Primary histiocytic dermatoses.
Ringel E, Moschella S.
Arch Dermatol. 1985 Dec;121(12):1531-41.
Newborn screening for lipid disorders.
Shao X, Steiner R, Peterson AL.
Curr Opin Lipidol. 2024 Jun 1;35(3):149-156. doi: 10.1097/MOL.0000000000000928. Epub 2024 Feb 26.
Hyperlipidaemia in children.
Lloyd JK.
Br Heart J. 1975 Feb;37(2):105-14. doi: 10.1136/hrt.37.2.105.
Familial xanthomatosis.
TAYLOR RE.
J Am Med Womens Assoc. 1955 Mar;10(3):82-3.
Lysosomal Acid Lipase Deficiency: Therapeutic Options.
Pastores GM, Hughes DA.
Drug Des Devel Ther. 2020 Feb 11;14:591-601. doi: 10.2147/DDDT.S149264. eCollection 2020.
